These tips can also be applied to search text ads and in some ways contradict the Reminder Ads Policy. These guidelines reaffirm that if a brand chooses to disclose a benefit, risk disclosures should follow. However, it also explains that if there are not enough characters to allow the full set of risk information, the risks should be ranked in order of severity. Here is the specific section dealing with this: At a minimum, a company should communicate the most serious risks associated with the product along with the benefit information as part of the character space-limited individual communication. Throughout the document, the
FDA states that if the pharmaceutical company finds that it cannot accurately present the risk information in the allotted space, it should reconsider displaying its brand name and information about the benefits in that specific ad unit. When these tips are applied to a text ad, they might look like the following: Campaign_Management_–_Google_AdWords 2 Many pharmaceutical jewelry retouching service companies are not comfortable leveraging this in paid search efforts and do not use this format. Almost all companies ensure that text ads adhere to the reminder guidelines mentioned above. Paid search for 'black box' drugs
A boxed warning appears on a prescription drug label for any drug that has a serious associated risk. If a drug has a side effect that could cause death, addiction, or serious injury, it is often referred to as a "black box." (Note: advertisers are not permitted to use reminder ads for "black box" medications.) For many years, both Google and Bing had specific ad formats for black box drugs. This included an additional line of text, similar to current teaser extensions, which read, “Click to see all safety and prescription information, including boxed warning. More information. "